BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10433067)

  • 1. Telomerase activity in benign and malignant adrenal tumors.
    Bamberger CM; Else T; Bamberger AM; Frilling A; Beil FU; Allolio B; Schulte HM
    Exp Clin Endocrinol Diabetes; 1999; 107(4):272-5. PubMed ID: 10433067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of telomerase activity in malignant pheochromocytoma.
    Kubota Y; Nakada T; Sasagawa I; Yanai H; Itoh K
    Cancer; 1998 Jan; 82(1):176-9. PubMed ID: 9428495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity as an indicator of potentially malignant adrenal tumors.
    Hirano Y; Fujita K; Suzuki K; Ushiyama T; Ohtawara Y; Tsuda F
    Cancer; 1998 Aug; 83(4):772-6. PubMed ID: 9708944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase activity in neuroendocrine tumors.
    Bockhorn M; Frilling A; Clauer U; Hertl M; Broelsch CE
    Int J Surg Investig; 2000; 2(3):219-25. PubMed ID: 12678522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
    Engelhardt M; Drullinsky P; Guillem J; Moore MA
    Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
    Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
    Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Telomerase expression in various lesions of adrenal cortex].
    Mao QZ; Rong S; Fan JH; Ji ZG; Li HZ; Zang MF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):188-9. PubMed ID: 12905801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of telomerase for the diagnosis of malignant well-differentiated endocrine tumours.
    Vezzosi D; Bouisson M; Escourrou G; Laurell H; Selves J; Seguin P; Pradayrol L; Caron P; Buscail L
    Clin Endocrinol (Oxf); 2006 Jan; 64(1):63-7. PubMed ID: 16402930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors.
    Tomoda R; Seto M; Tsumuki H; Iida K; Yamazaki T; Sonoda J; Matsumine A; Uchida A
    Cancer; 2002 Sep; 95(5):1127-33. PubMed ID: 12209700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
    Kołomecki K; Stepień H; Bartos M; Narebski J
    Neoplasma; 2001; 48(2):116-21. PubMed ID: 11478691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
    Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
    Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
    Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
    Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: a comparison of assays.
    Ernst A; Okkels H; Grove A; Svarrer T; Knudsen A; Madsen PH; Krarup HB
    Scand J Clin Lab Invest; 2006; 66(4):287-97. PubMed ID: 16777757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Telomerase as a tumor marker?].
    Hummel M; Heine B; Demel G; Stein H
    Verh Dtsch Ges Pathol; 1997; 81():312-7. PubMed ID: 9474885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pheochromocytomas as adrenal gland incidentalomas].
    Cerović S; Cizmić M; Milović N; Ajdinović B; Brajusković G
    Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():47-51. PubMed ID: 12584998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of telomerase activity: a potential diagnostic tool for colorectal carcinoma.
    Abe N; Watanabe T; Nakashima M; Masaki T; Mori T; Sugiyama M; Atomi Y
    Hepatogastroenterology; 2001; 48(39):692-5. PubMed ID: 11462905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance.
    Kanauchi H; Wada N; Clark OH; Duh QY
    Surgery; 2002 Dec; 132(6):1021-6; discussion 1026-7. PubMed ID: 12490850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression and significance of chromogranin A and synaptophysin in adrenal gland tumors].
    Feng C; Li HZ; Yan WG; Luo YF; Cao JL
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):486-8. PubMed ID: 16188147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1787-90. PubMed ID: 7752317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.